Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
11:02am, Tuesday, Aug 12, 2025
Veru Inc. (NASDAQ: VERU)
Quick read: management has executed strategic asset sales (FC2) and extinguished a residual royalty liability, which produced one‑time cash and non‑operating gains. At the same time the company remains a pre‑revenue biopharma with ongoing R&D (enobosarm, sabizabulin), lar...
11:01am, Tuesday, Aug 12, 2025
Taysha Gene Therapies, Inc. (TSHA on NASDAQ)
Quick summary - what's happening inside
Taysha raised a large equity tranche in May 2025 and entered a refinanced term‑loan in August 2025, materially improving near‑term liquidity while continuing to spend heavily on its lead gene‑therapy program TSHA...
10:06am, Tuesday, Aug 12, 2025
Snapshot - John Marshall Bancorp, Inc. (NASDAQ: JMSB)
Here's what's happening inside the company, focused on the income statement and the facts investors need to know - straight to the point.
Key points & statistics (from 10‑Q for quarter ended June 30, 2025)
* Net income - three months ended Jun...
10:05am, Tuesday, Aug 12, 2025
Snapshot - Lifeway Foods, Inc. (NASDAQ: LWAY)
What's happening inside: Lifeway is growing top-line volume in its core drinkable kefir business, investing in marketing and capacity, monetized an equity stake (Simple Mills) which materially boosted six‑month other income, and is taking steps to sec...
10:04am, Tuesday, Aug 12, 2025
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) - Quick read on what's happening inside
Snapshot - what's happening inside the company
- Management has materially reprioritized operations: commercial support for IGALMI® has been scaled back and R&D focus shifted to the highest‑priority programs (BXCL50...
10:03am, Tuesday, Aug 12, 2025
Snapshot - Greenpro Capital Corp. (NASDAQ: GRNQ)
What's happening inside
* The company is operating three segments (service, digital platform/crypto, real estate) while pushing its Labuan digital platform (Green‑X).
* Management raised cash via private placements in June 2025: 700,000 shares issu...
10:02am, Tuesday, Aug 12, 2025
LQR House Inc. (NASDAQ: YHC) - Quick read
Plain take: company is transitioning to an e‑commerce/brand model (CWS Platform + SWOL Tequila). Q2 shows improved gross margins vs. last year, but heavy operating losses, cash burn and related‑party concentration remain. July 2025 ATM ($~26M) substantial...
10:02am, Tuesday, Aug 12, 2025
Guerrilla RF, Inc. (PINK: GUER) - quick read on what's happening inside
Short version: revenue is down year-over-year, management has cut costs and reduced interest burden, non‑operating warrant remeasurements improved reported net loss this quarter, but the business still burns cash, is highly c...
10:01am, Tuesday, Aug 12, 2025
Snapshot - Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCU)
Quick reality: this is a blank‑check (SPAC) company with no operating business yet. Its financials reflect trust‑account cash and interest income rather than operating revenue. Management is actively searching for a business c...
09:15am, Tuesday, Aug 12, 2025
Snapshot - Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO)
What's happening inside the company (quick):
* Management is funding two late-stage device plays (AVIM with Medtronic; Virtue SAB with Terumo) and ramping clinical activity (BACKBEAT pivotal and planned Virtue pivotal).
* Company is in med...
09:14am, Tuesday, Aug 12, 2025
Snapshot - Monopar Therapeutics Inc (NASDAQ: MNPR)
Clinical-stage biopharma advancing ALXN1840 (Wilson disease) and MNPR‑101 radiopharmaceuticals; filing an NDA planned for early 2026 and continuing Phase 1 radiopharma trials while managing cash runway into late 2026.
Key facts & figures (straigh...
09:13am, Tuesday, Aug 12, 2025
QNB Corp. (OTCMKTS: QNBC) - Q2 2025 snapshot
Quick summary:
Net income rose to $3,883,000 in Q2 2025 (vs. $2,465,000 in Q2 2024). EPS (diluted) was $1.04 for the quarter and $1.74 year-to-date. Net interest income and margins improved, but non-interest expense and non-performing loans increased.
...
09:12am, Tuesday, Aug 12, 2025
Coya Therapeutics, Inc. (NASDAQ: COYA) - quick read on the company's Q2 2025 situation and income-statement health.
At a glance
* Cash (6/30/2025): $29,757,328
* Total assets (6/30/2025): $33,452,555
* Total liabilities (6/30/2025): $5,142,262
* Stockholders' equity (6/30/2025): $28,310,293
* Acc...
09:11am, Tuesday, Aug 12, 2025
Bitcoin Depot Inc. (NASDAQ: BTM) - Quick internal read
Straight to the point: Q2 2025 shows revenue and profitability momentum, a stronger cash position and a completed Up‑C restructuring - but the company still carries material legal, regulatory and control risks plus significant debt and recur...
09:10am, Tuesday, Aug 12, 2025
Aprea Therapeutics, Inc. (NASDAQ: APRE)
Short take - Clinical-stage oncology biotech focused on synthetic lethality (WEE1 inhibitor APR-1051; ATR inhibitor ATRN-119). Management is advancing two Phase‑1 programs and reports limited cash runway: ~ $16.5M on hand, continued quarterly losses and a f...
